Small Business Resources, Business Advice and Forms from AllBusiness.com
 

Entrepreneurial innovation in pharmaceutical research and development.

By Spencer, Lyle M., Jr.
Publication: Human Resource Planning
Date: Tuesday, December 1 1992

Change, and in particular innovation, in organizations is a perpetual dilemma. Although organizations are primarily designed to facilitate and control the production and provision of goods and services, innovation is key in order for a company to establish and maintain competitive advantage in

an increasingly complex world. In recent years, the popularity of entrepreneurship, intrapreneurship, change management, and innovation have been evident in the number of popular business books published. The magnitude of attention focused on innovation in business magazines, books, Wall Street analysts' reports, consulting firms' services, academic courses, and academic journals reflects a widespread, perceived need for more innovation. The 1990's have been years in which the demand for adaptability and speed of responsiveness has increased the need for innovation and the energetic styles described by "entrepreneurial" behavior.

Researchers have compared successful and unsuccessful innovation and change. Boyatzis (1982) applied a modified version of the extreme case, or criterion sample, methodology developed for the study of individual competencies of effective and less effective people in specific jobs. This method contrasts subjects selected to represent opposite outcomes. Three studies of high- and low-performing units within the same high-technology, manufacturing, and military organizations, identified three sets of variables that cause or were associated with successful innovation and implementation of change (Boyatzis and Greenley, 1986; Dalziel and Schoonover, 1988). They included: (1) individual competencies; (2) job role requirements; and (3) organizational structure, process and climate, or culture. For example, in one of the studies cited above, manufacturing plants that were effectively utilizing CAD/CAM (i.e., computer-assisted design and computer-assisted manufacturing) technology were compared to plants not effectively utilizing the same equipment and technology. Both sets of plants had the equipment delivered, and both were expected to be using the technology by division and corporate management. In the "effective using" set of plants, the CAD/CAM technology was used daily as an integral part of their operations. In the "not effectively using" set of plants, the technology was not used often (i.e., maybe once or twice a year) and in some plants the equipment had never been plugged into an electrical outlet!

In addition, make sure to read these articles:

  • Congressional Politicking Threatens Small Business...
  • Election year maneuvering will likely prevent Congress from breaking a logjam holding up a number of small business bills. But these measures would benefit the ......
  • Balancing Work and Life: Turning Work Trips into...
  • Time-pressed entrepreneurs often tack vacation onto business travel.
  • The Need for Newness
  • Keep your store fresh with new products or risk becoming irrelevant.
  • Proliance Pharmaceuticals Inc. Offers Alternative...
  • WAYNE, Pa.--(BW HealthWire)--September 16, 1998--The formation of a company providing the pharmaceutical and biotech industries with solutions to the capacity challenges in drug development was ......
  • Pharmaceutical Early-Stage Marketing Teams...
  • DURHAM, N.C. -- New product marketing teams must add commercial focus earlier in the drug research and development process, according to a new report published ......
  • Explore All the Stages of Drug Development With...
  • BERKELEY, Calif.--(BUSINESS WIRE)--June 3, 1998--The development of new drugs is a lengthy, complex and costly process. It can also prove profitable; for example, more than ......
  • Discovery to IND Filing, 2nd Edition Analyzes the...
  • DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c49335) has announced the addition of Discovery to IND Filing, 2nd Edition to their offering. The Discovery to IND ......
  • Research and Markets: Strategies for Innovation...
  • DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c19885) has announced the addition of Strategies for Innovation in Pharmaceutical R&D: Enhancing R&D Through Biotech Alliances and ......
  • Gene Express CEO Presents ``Clinically...
  • GENEVA -- Gene Express, Inc., a privately held genomic biotechnology company offering standardized, quantitative, multi-gene expression analysis products and services, announced that Dr. Terry Osborn, ......
  • Introducing the Pharma R&D Fact Book 2006...
  • DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c41414) has announced the addition of Espicom Business Intelligence's The Pharma R&D Fact Book 2006 to their offering....
  • The Role of Pharmacogenomics in Drug Development...
  • Dublin -- Research and Markets (http://www.researchandmarkets.com/reports/c43477) has announced the addition of "Modern Biopharmaceuticals: Design, Development and Optimization, 4 Volumes" to their offering. The biopharmaceutical market ......
  • NeoPharm's IL13-PE38QQR Drug Development...
  • Business Editors/Health/Medical Writers BIOWIRE2K LAKE FOREST, Ill.--(BUSINESS WIRE)--Feb. 6, 2004 NeoPharm, Inc. (Nasdaq/NM:NEOL) today announced that its IL13-PE38QQR development program has been accepted for inclusion ......
  • What Impact Will Cancer Stems Cells, siRNA's and...
  • DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c50635) has announced the addition of "Innovations in Cancer: Novel Therapeutics, New Diagnostics and Future R&D Strategies" to their ......
  • Inforonics Launches Pharmaceutical...
  • Business/Technology Editors and Health/Medical Writers LITTLETON, Mass.--(BUSINESS WIRE)--Oct. 15, 2001 Experienced TSP Reduces Time-to-Market, Increases Revenue Potential for Pharmaceutical Companies Inforonics, a leading total service ......
  • Medidata to Present at the Outsourcing of...
  • Business Editors/Health/Medical Writers Third Annual Outsourcing of Clinical Drug Development Conference NEW YORK--(BUSINESS WIRE)--Sept. 15, 2003 Edward Ikeguchi, MD, Medidata's Chief Medical Officer and Co-founder, ......
presented by